Research
Teaching
Innovation

Endocrinology and nutrition

Researchers

  • Amaya Peñalva Arigita

    Endocrinology and nutrition

  • Gemma Francisco

    Endocrinology and nutrition

  • Irela López Cobo

    Endocrinology and nutrition

  • Luis Vila Ballester

    Endocrinology and nutrition

    Phd

  • Manuel Sahún De La Vega

    Endocrinology and nutrition

    Phd

  • Maria Lecha

    Endocrinology and nutrition

  • Mercè Albareda

    Endocrinology and nutrition

    Phd

  • Mercè Fernández Miró

    Endocrinology and nutrition

    Phd

  • Thank you Lara

    Endocrinology and nutrition

  • Raquel Barnes

    Endocrinology and nutrition

  • Sara Torrejón Jaramillo

    Endocrinology and nutrition

  • Vanesa Cabrejo

    Endocrinology and nutrition

Contact the group

Form

  • Vila Ll, Lucas A, Donnay S, de la Vieja A, Wengrowicz S, Santiago P, Bandrés O, Velasco I, Garcia-Fuentes E, Ares S, Moreno JC, Espada M, Muñoz A, Galofré JC, Puig-Domingo M .

    Iodine Nutrition in Spain. Necessities for the future

    Endocrinology and Nutrition 2019; 67 (1): 61-69

  • Vila L, Puig-Domingo M. 83/18

    The Krakow Declaration: The last chance for Europe to eradicate iodine deficiency.

    Endocrinol Diabetes Nutr. 2018;65(10):553-555.

  • Martínez M, Soldevila B, Lucas A, Velasco I, Vila L, Puig-Domingo M. 82/18

    Hypothyroidism during pregnancy and its association with perinatal and obstetric morbidity: a review.

    Endocrinol Diabetes Nutr. 2018;65(2):107-113.

  • Arrizabalaga JJ, Jalón M, Espada M, Cañas M, Arena JM, Vila L. 81/18

    Iodine nutrition status and prevalence of abnormal TSH levels in schoolchildren aged 6-7 years in the autonomous community of the Basque Country.

    Endocrinol Diabetes Nutr. 2018;65(5):247-254.

  • Torres MT, Francés L, Vila Ll, Manresa JM, Fallguera G, Prieto G, Casamitjana R, Torán P.

    Iodine nutritional status of women in their first trimester of pregnancy in Catalonia

    BMC Pregnancy Childbirth 2017; 17 (1): 241

  • Morales C, Plana N, Arnau A, Matas L, Mauri M, Vila A, Vila Ll, Soler C, Montesinos J, Masana Ll, Pedro-Botet J.

    Causes of non-achievement of the therapeutic objective of low-density lipoprotein cholesterol in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. Studio EROMOT

    Clinic and Research in Arteriosclerosis 2017; 30(1): 1-9

  • Armario P, Jericó C, Freixa R, Vila Ll, Martín-Castillejos C, Rotllán M.

    Vascular Risk Integrated Care Area: a new organizational model for the global control of risk factors

    Basque Hypertensive Risk 2016; 34(2): 72-77

  • Fernández-Miró M, Chillarón JJ, Albareda M, Fontserè S, Colom C, Vila L, Pedro-Botet J, Flores LE-Roux JA; TEST-T1D study group. 1404

    Hypertriglyceridemic waist in type 1 diabetes patients: prevalence and related factors.

    Minerva Endocrinol. 2017;42(1):1-7.

  • Vila L, Donnay S, Arena J, Arrizabalaga JJ, Pineda J, Garcia-Fuentes E, García-Rey C, Marín JL, Serra-Prat M, Velasco I, López-Guzmán A, Luengo LM, Villar A, Muñoz Z, Bandrés O, Guerrero E, Muñoz JA, Moll G, Vich F, Menéndez E, Riestra M, Torres Y, Beato-Víbora P, Aguirre M, Santiago P, Aranda J, Gutiérrez-Repiso C. 1327

    Iodine status and thyroid function among Spanish schoolchildren aged 6-7 years: the Tirokid study.

    Br J Nutr. 2016;115(9):1623-31.

  • Fernández-Miró M, Chillarón JJ, Pedro-Botet J. 1326

    Testosterone deficiency, metabolic syndrome and diabetes mellitus.

    Med Clin (Ship). 2016;146(2):69-73.

Projects

    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Analysis of the evolution of the degree of control of patients with diabetes mellitus type 2, in the period 2011-2016, based on the intensification of primary hospital coordination,

    • DISTRICT ATTORNEY:

      Irela López Cobo

    • TYPE E:

      PI

    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Spanish multicenter study on the prevalence and incidence of heart failure in patients with type 2 diabetes in hospital consultations nationwide,

    • DISTRICT ATTORNEY:

      Spanish Cardiology Society and Spanish Diabetes Society

    • TYPE E:

      PINE TREE

    • Year 2018
    • Sant Joan Despí Moisès Broggi Hospital

    Analysis of the evolution of the degree of control of patients with diabetes mellitus type 2, in the period 2011-2016, based on the intensification of primary hospital coordination,

    • DISTRICT ATTORNEY:

      Irela López Cobo

    • TYPE E:

      PINE TREE

  • Endocrinology and nutrition

    Researcher
    • Year 2017
    • Comprehensive Care Center Dos de Maig Hospital

    Study of risk factors and determinants of neuropathic pain,

    • DISTRICT ATTORNEY:

      DOLORisk Consortium

    • TYPE E:

      PI

  • Endocrinology and nutrition

    Researcher
    • Year 2017
    • Sant Joan Despí Moisès Broggi Hospital

    Study of adherence to treatment with commercial food thickener in patients with liquid dysphagia from the area of ​​Baix Llobregat,

    • DISTRICT ATTORNEY:

      Amaya Peñalva Arigita

    • TYPE E:

      PI

    • Year 2017
    • Comprehensive Care Center Dos de Maig Hospital

    Study of risk factors and determinants of neuropathic pain,

    • DISTRICT ATTORNEY:

      DOLORisk Consortium

    • TYPE E:

      PINE TREE

    • Year 2017
    • Sant Joan Despí Moisès Broggi Hospital

    Study of adherence to treatment with commercial food thickener in patients with liquid dysphagia from the area of ​​Baix Llobregat,

    • DISTRICT ATTORNEY:

      Amaya Peñalva Arigita

    • TYPE E:

      PINE TREE

  • Endocrinology and nutrition

    Researcher
    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Randomized, double-blind, placebo-controlled study of parallel groups to evaluate the efficacy and safety of Alirocumab in patients with type 1 or type 2 diabetes treated with insulin and with high cardiovascular risk hypercholesterolemia not adequately controlled at the maximum tolerated doses of treatment LDL-C reducer

    • DISTRICT ATTORNEY:

      Sanofi aventis Groupe

    • TYPE E:

      RD2004

  • Endocrinology and nutrition

    Researcher
    • Year 2016
    • Comprehensive Care Center Dos de Maig Hospital

    Study on the sensory properties and acceptability of neutral commercial thickeners in elderly patients with oropharyngeal dysphagia,

    • DISTRICT ATTORNEY:

      Miriam Moreno, University of Vic- Central University of Catalonia and Vanesa Cabrejo Unit

    • TYPE E:

      PI

    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Randomized, double-blind, placebo-controlled study of parallel groups to evaluate the efficacy and safety of Alirocumab in patients with type 1 or type 2 diabetes treated with insulin and with hypercholesterolemia of high cardiovascular risk not adequately controlled at the maximum tolerated doses of treatment LDL-C reducer

    • DISTRICT ATTORNEY:

      Sanofi aventis Groupe

    • TYPE E:

      RD2004

Lines of action

  • Adequacy and effectiveness of primary prevention of arteriosclerotic disease
  • Iodine nutrition and thyroid function
  • Nutritional support: Nutritional support and education for complex chronic patients and treatment and control of patients with dysphagia
  • Impact of hypogonadotropic hypogonadism and its treatment in patients with type 1 diabetes
  • Metabolic control and well being in type 1 diabetes

Documents

Information of interest

Links

Accessibility by WAH